Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories

Diagnostic Microbiology and Infectious Disease

Volumn 44, Issue 4, 2002, Pages 367-377

  Mathai, Dilip ^a   Rhomberg, Paul R ^b   Biedenbach, Douglas J ^b   Jones, Ronald N ^b,c   Kapil, Arti ^a,d   Chitnis, D S ^a,e   Lalitha, M K ^a   Arora, Anita ^a,f   Metha, Ajita ^a,g   Sardana, Raman ^a,h   Venkatachalam, Nirmala ^a,i   Krishna Prakash, S ^a,j   Ayyagiri, Archana ^a,k   Kelkar, Rohini ^a,l  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b JMI LABORATORIES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^e CHOITHRAM HOSPITAL AND RESEARCH CENTRE   (India)

^f ESCORTS HEART INSTITUTE AND RESEARCH CENTRE   (India)

^g P D HINDUJA NATIONAL HOSPITAL   (India)

^h INDRAPRASTHA APOLLO HOSPITAL   (India)

ⁱ Mallaya Hospital   (India)

^j MAULANA AZAD MEDICAL COLLEGE   (India)

^k Sangay Gandhi Post Grad I of M S   (India)

^l TATA MEMORIAL HOSPITAL   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; IMIPENEM; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG POTENCY; DRUG SELECTIVITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HOSPITAL LABORATORY; IN VITRO STUDY; INDIA; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; SALMONELLA; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; HUMANS; INDIA; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS;

EID: 12244272109     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00466-2     Document Type: Article

References (52)

1. Andrews J.M. BSAC standardized disc susceptibility testing method. J Antimicrobial Chemother. 48:(Suppl 1):2000;43-57.
2. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet. 353:1999;1216-1221.
3. Arya S.C. Emerging antibiotic resistance in Indian communities. Clin Infect Dis. 25:1997;944-945.
4. Aravindan N., Lalitha M.K. Cefoperazone An analysis of results in the pediatric population from a post marketing surveillance study in hospitalized patients . Indian J Pediatr. 65:1998;89-98.
5. Bhat K.G., Andrade A.T., Karadesai S.G., Hemashettar B.M., Patil C.S. Antimicrobial susceptibility of Salmonella typhi to quinolones & cephalosporins. Indian J Med Res. 107:1998;247-251.
6. Chandel D.S., Chaudhry R., Dhawan B., Pandey A., Dey A.B. Drug-resistant Salmonella enterica serotype paratyphi A in India. Emerging Infectious Diseases. 6:2000;420-421.
7. Chitrnis, D. S., Shukla, A., & Patel, B. (1977). 100 years of widal test & its reappraisal in an endemic area. Indian Journal of Medical Research, 105,53-59.
8. Cormican M.G., Marshall S.A., Jones R.N. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol. 34:1996;1880-1884.
9. Antimicrobial susceptibility of bacteria isolated from hospitalized patients with acute serious infections (a multicenter study). Indian Journal of Internal Medicine. 5:(Suppl 5):1995;36-44.
10. Garau J. The clinical potential of fourth-generation cephalosporins. Diagn Microbiol Infect Dis. 31:1998;479-480.
11. Garg P., Chakraborty S., Basu I., Datta S., Rajendran K., Bhattacharya T., Yamasaki S., Bhattacharya S.K., Takeda Y., Nair G.B., Ramamurthy T. Expanding multiple antibiotic resistance among clinical strains of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect. 124:2000;393-399.
12. Gupta A., Swarnkar N.K., Choudhary S.P. Changing antibiotic sensitivity in enteric fever. J Trop Pediatr. 47:2001;369-371.
13. Gupta, V., Ray, P., & Sharma M. (1999). Antimicrobial resistance pattern of Shigella and non-typhi Salmonella isolated from patients with diarrhoea. Indian Journal Medical Research, 109,53-57.
14. IBIS. (1999). Prospective multicentre hospital surveillance of Streptococcus pneumoniaedisease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN) Lancet, 353,1216-1221.
15. Jesudason, M., & Jeyaraj, L. K. (2002). Increasing minimum inhibitory concentration of cefazolin for Salmonella typhi. Indian Journal Medical Research, 112,183-185.
16. Jesudason M.V., John R., John T.J. The concurrent prevalence of chloramphenicol-sensitive and multi-drug resistant Salmonella typhi in Vellore, S. India. Epidemiol Infect. 116:1996;225-227.
17. Jesudason M.V., Anandaraj W.S., Jegadeesan P. Incidence of methicillin-resistant coagulase-positive and coagulase-negative staphylococci in blood cultures. Indian J Med Res. 105:1997;155-157.
18. John M. Decreasing clinical response of quinolones in the treatment of enteric fever. Indian J Med Sci. 55:2001;189-194.
19. Jones R.N., Pfaller M.A., Allen S.D., Gerlach E.H., Fuchs P.C., Aldridge K.E. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6,000 recent clinical isolates from five medical centers. Diagn Microbiol Infect Dis. 14:1991;361-364.
20. Jones R.N. The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis. 25:1996;153-161.
21. Jones R.N. Summation β-lactam resistance surveillance in the Asia-Western Pacific region . Diagn Microbiol Infect Dis. 35:1999;333-338.
22. Jones R.N. Detection of emerging resistance patterns within longitudinal surveillance systems data sensitivity and microbial susceptibility . J Antimicrobial Chemother. 46:(Suppl T2):2000;1-8.
23. Kanungo R., Rajalakshmi B. Serotype distribution & antimicrobial resistance in Streptococcus pneumoniae causing invasive & other infections in south India. Indian J Med Res. 114:2001;127-132.
24. Krishnan P.U., Pereira B., Macaden R. Epidemiological study of an outbreak of Serratia marcescens in a haemodialysis unit. J Hosp Infect. 18:1991;57-61.
25. Lalitha, M. K., Nisha, A. K., Bhattacharya, S. S., Usha, R., & Lal, H. M. (1990). Susceptibility pattern of bacterial isolates to lomefloxacin. Indian Journal of Medical Research, 91,182-184.
26. Lalitha M.K., Thomas K., Manoharan A., Song J., Steinhoff M.C. Changing trend in susceptibility pattern of Streptococcus pneumoniae to penicillin in India. Indian J Med Res. 110:1999;164-168.
27. Lalitha M.K., Pai R., Manoharan A., Jesudason M.V., Brahmadathan K.N., Srivastava A., Chandy M. Systemic bacterial infections in bone marrow transplant patients. Indian J Cancer. 37:2000;10-14.
28. Mathai, D., Abraham, A., John, L. R., Jesudason, M., Lalitha, M. K., Abraham, O. C., Molly, T., & John, T. J. (1998). Randomized control study of chloramphenicol vs ofloxacin in the treatment of enteric fever: A pharmacoeconomic analysis. Journal of the Association of Physician of India, 46, 991-996.
29. Mathai E., Richard V., John G., Brahmadathan K.N. Typing of Acinetobacter baumannii isolated from hospital-acquired respiratory infections in a tertiary care centre in southern India. J Hosp Infect. 47:2001;159-162.
30. Masterton R.G. Surveillance studies how can they help the management of infection? J Antimicrobial Chemother. 46:2000;53-58. (Topic 2),
31. Mathur, S. K., Singhal, S. L., Prasad, K. N., Kishore, J., & Ayyagari, A. (1994). Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in tertiary care hospital. Indian Journal of Medical Microbiology, 12,96-101.
32. Mehta, A., & Rodriguez, C. (1995). Business India, 14, 169-172.
33. Mehndiratta P.L., Vidhani S., Mathur M.D. A study on Staphylococcus aureusstrains submitted to a reference laboratory. Indian J Med Res. 114:2001;90-94.
34. MIMS India (2000). In: Gulhati, C. M., ed. Monthly Index of Medical Specialties. Indraprastha Press, New Delhi, India.
35. Molly, T. (1998). Guide Lines to Antibiotic policy. Proceedings of workshop sponsored by WHO, 22nd-23rd January 1998. In: Molly, T., ed. Empee graphics. Vellore. Tamilnadu India.
36. Monnet D.L., Biddle J.W., Edwards J.R., Culver D.H., Tolson J.S., Martone W.J., Tenover F.C., Gaynes R.P. Evidence of interhospital transmission of extended-spectrum β-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol. 18:1997;492-498.
37. A pilot programme of MRSA surveillance in India. J Assoc Physicians India. 45:1997;443-445.
38. Nag V.L., Ayyagari A., Venkatesh V., Ghar M., Yadav V., Prasad K.N. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India. Indian J Chest Dis Allied Sci. 43:2001;13-17.
39. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - Fifth Edition: Approved standard M7-A5. 2000;NCCLS, Wayne, PA.
40. Performance standards for antimicrobial disk susceptibility tests. 2000;NCCLS, Wayne, PA. Seventh edition: Approved standard M2-A7.
41. Performance standards for antimicrobial susceptibility testing Twelfth informational supplement. M100-S12 . 2002;NCCLS, Wayne, PA.
42. Navaneeth B.V., Belwadi S., Suganthi N. Urinary pathogens' resistance to common antibiotics a retrospective analysis . Tropical Doctor. 32:2002;20-22.
43. Peter J.B. Antimicrobial resistance in India and the United States. Clin Infect Dis. 23:1996;1315-1316.
44. Pfaller M.A., Hollis R.J., Sader H.S. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. Isenberg H.D. Clinical Microbiology Procedures Handbook, vol. 2. 1992;10.5c.1-12 American Society for Microbiology, Washington, DC.
45. Pfaller M.A., Wendt C., Hollis R.J., Wenzel R.P., Fritschel S.J., Neubauer J.J., Herwaldt L.A. Comparative evaluation of an automated ribotyping system versus pulsed-field gel electrophoresis for epidemiological typing of clinical isolates of Escherichia coli and Pseudomonas aeruginosa from patients with recurrent gram-negative bacteremia. Diagn Microbiol Infect Dis. 25:1996;1-8.
46. Rahal K., Wang F., Schindler J., Rowe B., Cookson B., Houvinen P., Marton A., Lalitha M.K., Semina N., Kronvall G., Guzman M. Reports on surveillance of antimicrobial resistance in individual countries. Clin Infect Dis. 24:(Suppl 1):1997;S169-S175.
47. Ram S., Gupta R., Gaheer M., Uppal S. Prevalence of multi-drug resistant organisms in an intensive care burn unit. Indian J Med Res. 111:2000;118-120.
48. Sanchez M.L., Jones R.N. Etest, an antimicrobial susceptibility testing method with broad clinical and epidemiological application. Antimicrobial Newsletter. 8:1993;1-8.
49. Song J.H., Lee N.Y., Ichiyama S., Yoshida R., Hirakata Y., Fu W., Chongthaleong A., Aswapokee N., Chiu C.H., Lalitha M.K., Thomas K., Perera J., Yee T.T., Jamal F., Warsa U.C., Vinh B.X., Jacobs M.R., Appelbaum P.C., Pai C.H. Spread of drug-resistant Streptococcus pneumoniae in Asian countries Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study . Clin Infect Dis. 28:1999;1206-1211.
50. Verma S., Joshi S., Chitnis V., Hemwani N., Chitnis D. Growing problem of methicillin resistant staphylococci-Indian scenario. Indian J Med Sci. 54:2000;535-540.
51. Wilson W.R. The role of fourth-generation cephalosporins in the treatment of serious infectious diseases in hospitalized patients. Diagn Microbiol Infect Dis. 31:1998;473-477.
52. Wiseman L.R., Lamb H.M. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs. 54:1997;117-140.